Cancers — Editors

Journal Contact

Cancers Editorial Office
MDPI AG, Klybeckstrasse 64, 4057 Basel, Switzerland
Tel. +41 61 683 77 34; Fax: +41 61 302 89 18

Prof. Dr. Robert H. Weiss *
Founding Editor-in-Chief
Division of Nephrology and Cancer Center, University of California, Davis, CA 95616, USA; and Nephrology Section, Sacramento VAMC; and NCI Early Detection Research Network (EDRN), USA
Interests: cyclins and cyclin inhibitors; cancer growth control; metabolomics and proteomics; polycystic kidney disease
* Founding Editor-in-Chief 2009-2015

Dr. Robert A. Anders
Johns Hopkins School of Medicine, Department of Pathology, Division of GI & Liver Pathology, 1550 Orleans St., Cancer Research Building II Rm 346, Baltimore, Maryland 21231, USA
Interests: liver cancer; hepatitis; bile duct cancer; bile duct development; human liver pathology
Dr. Brigitta G. Baumert
Department of Radiation-Oncology, MediClin Robert Janker Clinic & University of Bonn Med. Centre, Cooperation Unit Neurooncology, Bonn, Germany
Interests: CNS tumors; sarcomas; pet imaging; new MRI imaging techniques introduced for radiation therapy; new international trials in primary and secondary brain tumors
Contribution: Special Issue: Cancer Cell Imaging
Special Issue: Re-Irradiation, Chemotherapy, New Drugs for the (Re)-Treatment of Recurrent Gliomas
Dr. Don Benjamin
Growth & Development Unit, Rm. 583 Biozentrum, University of Basel, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland
Interests: mTOR; cancer metabolism; glycolysis; signal transduction; mRNA stability
Contribution: Special Issue: Cancer Signaling Pathways and Crosstalk
Dr. William Chi-shing Cho
Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China
Interests: cancer biomarker; Chinese medicine; diabetes mellitus; evidence-based medicine; genomics; microRNA; molecular diagnostics; nasopharyngeal carcinoma; non-small cell lung cancer; proteomics
Contribution: In other journals:
Special Issue: Advances in Molecular Oncology (special issue)
Special Issue: Advances in Cancer Diagnosis
Special Issue: Molecular Classification of Human Cancer and Its Role in Tailored Cancer Therapy
Special Issue: Advances in Molecular Oncology 2014
Special Issue: Recent Advance in Targeted Therapy in Medicine
Special Issue: Advances in Molecular Oncology
Special Issue: Molecular Classification of Human Cancer: Diagnosis and Treatment
Special Issue: MicroRNA in Various Disease States as Biomarkers
Special Issue: Acupuncture – Basic Research and Clinical Application
Special Issue: Precision Medicine—From Bench to Bedside
Dr. Jonas Cicenas
CALIPHO Group, Swiss Institute of Bioinformatics, CMU - 1, rue Michel Servet, CH-1211 Geneva 4, Switzerland
Interests: breast cancer; prostate cancer; acute myeloid leukemia (AML); kinases
Contribution: Special Issue: Kinases and Cancer
Special Issue: Small GTPases in Cancer
Prof. Dr. Robert Coleman
Department of Oncology, Cancer Clinical Trials Centre, Academic Unit of Clinical Oncology, Broomcross Building, Weston Park Hospital, University of Sheffield, Sheffield, S10 2SJ, UK
Interests: cancer induced bone disease especially with relevance to breast cancer; the development of bone targeted agents in oncology, evaluation of bone markers in oncology to aid drug development and provide both prognostic and predictive information in the management of metastatic bone disease, and the assessment of adverse effects of cancer treatments on bone health and evaluation of various treatment strategies
Contribution: In other journals:
Special Issue: Prevention and Treatment of Bone Metastases from Breast Cancer
Prof. Dr. Ronald A. DePinho
President, MD Anderson Cancer Center, Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Interests: cancer drug and biomarker development; cancer gene discovery; stem cell biology and development of genetically engineered mouse models to study cancer in humans
Dr. Doriano Fabbro
Executive Director, Expertise Kinase Platforrm, CPC, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland
Interests: protein kinases regulation; structure; screening and drug discovery
Prof. Dr. Alfio Ferlito
MD, FRCSEd ad hominem, FRCS (Eng, Glasg, Ir) ad eundem, FDSRCS ad eundem, FACS, FHKCORL, FRCPath, FASCP, IFCAP, Coordinator of the IHNSG; Professor of Otorhinolaryngology-Head and Neck Surgery; University of Udine School of Medicine, Udine 33100, Italy
Interests: head and neck cancer; neuroendocrine neoplasms of the head and neck; distant metastases from head and neck cancer
Dr. Salvador Villà Freixa
Department of Radiation Oncology, Hospital Universitari Germans Trías, ICO Badalona, C/Canyet s/n, 08916 Badalona, Catalunya, Spain
Interests: CNS tumours; prostate cancer; sterotactic RT
Dr. Samy L. Habib
1 Department of Cellular and Structural Biology, The University of Texas Health Science Center, San Antonio, TX, USA
2 Geriatric Research, Education and Clinical CTR, South Texas veterans Health System, San Antonio, TX, 78229, USA
Interests: tumor supressor genes; DNA damage and repair pathways; diabetes and cancer; kidney and liver cancer; cell signaling; apoptosis and proliferation; cancer biomakers
Prof. Dr. Jörg Haier
Comprehensive Cancer Center Muenster, International Patient Management, University Hospital Muenster, Waldeyerstr. 1, 48149 Muenster, Germany
Interests: gastraintestinal cancer; metastasis; cell adhesion; cell migration; chemotaxis
Contribution: Special Issue: Epigenetics of Cancer Progression
Special Issue: Organ-Specific Metastasis Formation
Prof. Dr. Carl-Henrik Heldin
Ludwig Institute for Cancer Research Ltd., Science for Life Laboratory, Uppsala University, Box 595, Biomedical Center, SE-751 24 Uppsala, Sweden
Interests: growth factors; signal transduction mechanisms; receptors; kinases; angiogenesis
Prof. Dr. W. Martin Kast
Walter A. Richter Cancer Research Chair, Professor of Molecular Microbiology & Immunology, Obstetrics & Gynecology and Urology, Norris Comprehensive Cancer Center (NRT 7507), University of Southern California, 1450 Biggy Street, MC 9601, Los Angeles, CA90033, USA
Interests: design of HPV immunotherapeutics; developing new and effective therapies for cervical cancer; prostate cancer and melanoma
Contribution: Special Issue: Cancer Vaccines and Immunotherapy
Dr. Charles H. Lawrie
Lymphoid Malignancy Research Group, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK
Interests: cancer; lymphoma; leukemia; microarray; microRNA; biomarkers; non-coding RNA
Contribution: Special Issue: Leukemia
Dr. Chyi-Chia Richard Lee
Laboratory of Pathology, National Cancer Institute, Building 10, Room 2S235J, 10 Center Drive, Bethesda, MD 20892, USA
Interests: melanoma; skin cancers; dermatopathology; skin pathology; melanocytic skin lesions
Contribution: Special Issue: Current Concepts in the Diagnosis and Treatment of Cutaneous Melanoma
Special Issue: Skin Cancer
Special Issue: Current Topics in Cutaneous Melanoma
Dr. Huey-Jen Lin
Department of Medical Laboratory Sciences, College of Health Sciences, University of Delaware, Newark, DE 19716, USA
Interests: dna methylation; cancer invasion and metastasis in breast and pancreatic cancers; carcinoma-associated fibroblasts; epithelial-mesenchymal transition; and akt signaling pathway
Contribution: Special Issue: Cancer-Associated Fibroblasts
Prof. Dr. Dario Marchetti
Director, Center of the Biomarker Research Program at Houston Methodist Research Institute, and Professor of Pathology and Genomic Medicine at Methodist Hospital, MS: R7-102, 6670 Bertner Avenue, Houston, TX 77030, USA
Interests: the biology and therapeutic utility of circulating tumor cells (CTCs); mechanisms of brain metastasis; breast cancer dormancy; roles of heparanase in development and disease
Contribution: In other journals:
Special Issue: Brain Metastasis
Special Issue: Brain Metastasis 2014
Special Issue: Circulating Tumor Cells
Special Issue: Brain Metastasis 2016
Dr. Enrique A. Mesri
Viral Oncology Research Program, Sylvester Comprehensive Cancer Center, University of Miami AIDS Malignancies Program, Dev. Center for AIDS Research, Department of Microbiology and Immunology, University of Miami, Miller School of Medicine, 1550 NW, 10th Ave, PAP bldg Ste 109B (R138), Miami, FL 33136, USA
Interests: molecular mechanisms of viral oncogenesis of Kaposi\'s sarcoma; KSHV and AIDS-associated malignancies with an emphasis in translational cancer research; cell signaling, angiogenesis and genomics
Prof. Dr. Alba Minelli
Biosciences Unit, Department of Experimental Medicine, University of Perugia, P.le Gambuli 06123, Perugia, Italy
Interests: prostate cancer; oxidative stress; inflammation
Contribution: Special Issue: Oxidative Stress and Cancer
Special Issue: Antioxidants in Cancer
Dr. Constantine S. Mitsiades
450 Brookline Ave, Room HIM346, Harvard Institutes of Medicine Building, Boston, MA 02115, USA
Interests: hematologic malignancies; novel therapeutics; signal transduction inhibitors; tumor microenvironment; bone metastases; clinical trial design; prognostic markers; multiple myeloma; plasma cell dyscrasias; insulin-like growth factor; IGF1R; heat shock protein; proteasome; histone deacetylase; kinase
Contribution: Special Issue: Tumor Cell Genesis and Its Microenvironment: Chicken or the Egg
Prof. Dr. Margareta Mueller
Head, Molecular Cell Biology Laboratory, Hochschule Furtwangen University, Campus Villingen-Schwenningen, Jakob Kienzle Str 17, 78054 Villingen-Schwenningen, Germany
Interests: tumor stroma interaction; angiogenesis; inflammation and cancer; growth factors and cytokines; proteases; IL-6 signalling
Contribution: Special Issue: Tumor Cell Genesis and Its Microenvironment: Chicken or the Egg
Prof. Dr. Hasan Mukhtar
Department of Dermatology, University of Wisconsin, Medical Science Center, Rm 4385, 1300 University Avenue, Madison, WI 53706,USA
Interests: apoptosis; chemical carcinogenesis; chemoprevention, cytochrome P450; metabolic basis of toxicity; photocarcinogenesis; tumor promotion/prevention
Prof. Dr. Akira Nakagawara
Chiba Cancer Center, Director of Research Institute; and Division of Biochemistry and Innovative Cancer Therapeutics, 666-2 Nitona, Chuo-ku, Chiba 260-8717, Japan
Interests: molecular biology of cancer; neuroblastoma and neural development
Prof. Dr. Masanobu Oshima
Division of Genetics, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan
Interests: cancer genetics; molecular pathology of gastrointestinal cancers; cancer stem cell and Wnt signaling
Contribution: Special Issue: Exploring Inflammation in Cancers
Dr. George Pentheroudakis
Medical Oncologist, Department of Medical Oncology, Ioannina University Hospital, Greece
Interests: GI cancer; cancer of unknown primary; cancer and pregnancy; adolescent/young adult oncology and phase I/pharmacokinetic studies of investigational agents
Prof. Dr. Sven Perner
Institute of Pathology, University Hospital of Bonn, Sigmund-Freud-Str. 25, 53127 Bonn, Germany
Interests: understanding of the molecular biology of prostate cancer and the development of predictive biomarkers; genetics; molecular biology; TMPRSS2-ERG gene fusion; gene translocations; biomarker development
Contribution: Special Issue: Prostate Cancer
Dr. Christian Pilarsky
Klinik und Poliklinik für Viszeral-, Thorax- und Gefäßchirurgie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstraße 74, 01307 Dresden, Germany
Interests: pancreas cancer; apoptosis; microarrays; signal transduction networks; tumor stroma interaction; prostate cancer; biomarker
Contribution: Special Issue: Pancreatic Cancer
Prof. Dr. Dirk Rades
Department of Radiation Oncology, University of Lübeck, UK-SH Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany
Website: http://www.strahlentherapie-lü
Interests: radiation oncology; metastases; radiochemotherapy; CNS tumors; head and neck cancer; gastrointestinal cancer
Dr. Michael W. Retsky
Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
Interests: cancer research; electron beam technology
Contribution: Special Issue: Surgery Induced Tumorigenesis in Breast and Other Cancers: An Inconvenient Truth?
In other journals:
Special Issue: Neural Networks and Sensors
Special Issue: Neural Networks and Sensors
Prof. Dr. Afshin Samali
Director of Apoptosis Research Centre, School of Natural Sciences, National University of Ireland - Galway, University Road, Galway, Ireland
Interests: apoptosis; cell death; autophagy; TRAIL; heat shock proteins; Endoplasmic Reticulum stress; hypoxia
Contribution: Special Issue: Cell Death and Cancer
Dr. Thomas D. Schmittgen
Division of Pharmaceutics, College of Pharmacy, Ohio State University, Parks Hall, 500 West 12th Avenue, Columbus, OH 43210, USA
Interests: noncoding RNA; microRNA; cancer; quantitative RT-PCR; pancreatic cancer
Prof. Dr. Roderich E. Schwarz
Goshen Center for Cancer Care, Indiana University Health, 200 High Park Ave., Goshen, IN 46526, USA
Interests: bile duct cancer; gastric cancer; liver cancer; pancreatic cancer
Contribution: Special Issue: Gastric Cancer
Prof. Dr. Sandip Kumar SenGupta
Department of Pathology & Molecular Medicine, Queen's University, Canada
Interests: breast cancer pathology; immunohistochemistry; prognostic and predictive factors; biomarkers
Contribution: Special Issue: Breast Cancers: Pathology and Biomarkers
Prof. Dr. David A. Sherris
Department of Otolaryngology, University at Buffalo, 1237 Delaware Ave., Buffalo, NY 14209, USA
Interests: chronic sinusitis; endoscopic sinus surgery; rhinoplasty; airway obstruction; fungal sinusitis
Dr. Giulio C. Spagnoli
Laboratory of Oncology, Institute of Surgical Research and Hospital Management, University of Basel, c/o ZLF, Hebelstrasse 20, CH-4031 Basel, Switzerland
Interests: tumor immunology; cellular immunology; cancer cell biology
Dr. Eike Staub
Head of Exploratory Biomarker Analysis, Merck Serono, Darmstadt, Germany; Lecturer of Bioinformatics, Hochschule Mannheim, Germany
Interests: cancer drug target identification and validation; cancer drug discovery; oncogenomics for preclinical models & for patient stratification; bioinformatics for prediction of disease genes; analysis of protein, gene and genome evolution
Dr. Tomoharu Sugie
Department of Surgery, Kansai Medical University, 2-3-1 Shinmachi, Hirakata, 573-1191 Osaka, Japan
Interests: breast surgery; cancer immunology
Contribution: Special Issue: Breast Cancer
Special Issue: Breast Cancer Biology and Treatment
Dr. Ugo Testa
Medical Oncology Section, Department of Hematology and Oncology, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
Dr. Kwong Yok Tsang
Cellular Immunology Group, Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, MSC-1750, Building 10, Room 8B08, Bethesda, MD 20892, USA
Interests: the role of the human immune response to tumor-associated antigens. We are working to define and develop immunodominant determinants and modifications of those determinants toward the optimal activation of human immune responses to tumor-associated antigens. Additionally, we are involved in studying mechanisms to enhance the potency of antigen-presenting cells for specific T cell activation. We are also developing immunologic methods and immunoassays to better define the efficacy of vaccine therapies for a range of human cancers.
Contribution: Special Issue: Immune Responses to Human Prostate Cancer
Dr. Asad Umar
Gastrointestinal & Other Cancers Research Group, Division of Cancer Prevention, National Cancer Institute, 6130 Executive Blvd, EPN2142, Rockville, MD 20852, USA
Interests: gastrointestinal; skin, and hematolymphoid cancers prevention policies and future research directions
Dr. Guillermo Velasco
Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, C/José Antonio Nováis nº 2, 28040 Madrid, Spain
Interests: autophagy; ER stress; gliomas; cannabinoid antitumoral action; ceramide signaling
Contribution: Special Issue: Autophagy and Cancer
Dr. Penghui Zhou
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave., Boston, MA 02115, USA
Interests: Cancer immunology; T cell therapy
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert